Aktiviertes Protein C im septischen Schock – pro

Schlüsselwörter

aktiviertes Protein C - Drotrecogin alfa - Sepsis - septischer Schock

Keywords

aktivated protein C - drotrecogin alfa - sepsis - septic shock

Literatur

• 1 Angus D C. et al . The effect of drotrecogin alfa (activated) on long-term survival after severe sepsis.  Crit Care Med. 2004;  32 2199-2206
• 2 Bernard G R. et al . Efficacy and safety of recombinant human activated protein C for severe sepsis.  N Engl J Med. 2001;  344 699-709
• 3 Eichacker P Q. et al . Reassessing recombinant human activated protein C for sepsis.  Crit Care Med. 2005;  33 2426-8
• 4 Levy M M. et al . The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis.  Intensive Care Med. 2010;  36 222-231
• 5 Vincent J L. et al . Drotrecogin alfa (activated) treatment in severe sepsis from the global open-label trial ENHANCE.  Crit Care Med. 2005;  33 2266-2267